Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis.
Zicong YouWeijun ZhouJunyan WengHaizhan FengPeiqiao LiangYuhua LiFujun ShiPublished in: Cancer cell international (2021)
The E75 vaccine was effective and safe in patients with breast cancer. The GP2 vaccine could elicit a strong immune response, but more trials are needed to confirm its clinical efficacy.